Supor Pharmaceuticals

Zhejiang Supor Pharmaceuticals Co., Ltd., a subsidiary of the diversified Supor Group, is a comprehensive pharmaceutical enterprise based in China that specializes in the development and production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company maintains a strong focus on therapeutic areas including cardiovascular health, the central nervous system, and anti-infectives. Operating from high-standard manufacturing facilities in Shaoxing, Supor Pharmaceuticals adheres to international GMP standards and has successfully passed inspections from global regulatory bodies such as the US FDA and EU authorities. The company serves as a critical link in the global pharmaceutical supply chain, exporting high-quality chemical drugs and intermediates to markets worldwide. By leveraging the industrial expertise of its parent group, Supor Pharmaceuticals continues to expand its portfolio of generic medications and specialized chemical synthesis capabilities.